+ 0.40
+ 0.12%
+ 1.41
+ 0.41%
+ 1.40
+ 0.34%
+ 1.00
+ 0.6%

Why Gritstone Oncology's Stock is Trading Higher Today

January 20, 2021 9:53 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Gritstone Oncology's Stock Price And Volume Action

Gritstone Oncology (NASDAQ:GRTS) is currently up 6.87% to a price of $21.46. The stock's volume is currently 2.72 million, which is roughly 83.78% of its recent 30-day volume average of 3.24 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Gritstone Oncology shares were trading higher after the company announced an agreement with Genevant to obtain a nonexclusive license to Genevant's LNP technology to develop and commercialize self-amplifying RNA vaccines against COVID-19.

Insights On Recent Price Action

The moving average price of the stock over the past 50 days was $3.98 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $22.47 and as low as $2.54.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.


Movers Trading Ideas

Related Articles

12 Health Care Stocks Moving In Tuesday's Intraday Session

  read more

60 Biggest Movers From Yesterday

Gainers Olink Holding AB (NASDAQ: OLK) shares surged 80% to close at $36.00 on Thursday after the company priced its IPO at $20 per share. read more

42 Stocks Moving In Thursday's Mid-Day Session

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) climbed 64.2% to $5.73. Cellect Biotechnology and Quoin Pharmaceuticals reported a strategic merger. read more

38 Stocks Moving in Tuesday's Pre-Market Session

Gainers Artelo Biosciences, Inc. (NASDAQ: ARTL) shares rose 126.9% to $2.36 in pre-market trading after climbing over 8% on Monday. The company, last month, reported upbeat Q1 earnings. read more